Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Glioblastoma Patients

NCT02728349 is registered in ClinicalTrials.gov with Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd as lead sponsor.

NCT NCT02728349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02728349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Glioblastoma Patients
Lead sponsor
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
April 12, 2016
Completion date
September 13, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma